Annual Accounts Receivable
$99.00 K
+$3000.00+3.13%
December 31, 2023
Summary
- As of February 7, 2025, OBIO annual accounts receivable is $99.00 thousand, with the most recent change of +$3000.00 (+3.13%) on December 31, 2023.
- During the last 3 years, OBIO annual accounts receivable has fallen by -$69.00 thousand (-41.07%).
- OBIO annual accounts receivable is now -41.07% below its all-time high of $168.00 thousand, reached on December 31, 2020.
Performance
OBIO Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Receivable
$115.00 K
+$35.00 K+43.75%
September 30, 2024
Summary
- As of February 7, 2025, OBIO quarterly accounts receivable is $115.00 thousand, with the most recent change of +$35.00 thousand (+43.75%) on September 30, 2024.
- Over the past year, OBIO quarterly accounts receivable has increased by +$29.00 thousand (+33.72%).
- OBIO quarterly accounts receivable is now -32.75% below its all-time high of $171.00 thousand, reached on June 30, 2023.
Performance
OBIO Quarterly Accounts Receivable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Receivable Formula
Accounts Receivable = Total Credit Sales − Amount Collected from Credit Sales
OBIO Accounts Receivable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.1% | +33.7% |
| 3 y3 years | -41.1% | +19.8% |
| 5 y5 years | -41.1% | +19.8% |
OBIO Accounts Receivable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -18.2% | +3.1% | -32.8% | +71.6% |
| 5 y | 5-year | -41.1% | +3.1% | -32.8% | +71.6% |
| alltime | all time | -41.1% | +3.1% | -32.8% | +71.6% |
Orchestra BioMed Holdings Accounts Receivable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $115.00 K(+43.8%) |
| Jun 2024 | - | $80.00 K(+19.4%) |
| Mar 2024 | - | $67.00 K(-32.3%) |
| Dec 2023 | $99.00 K | $99.00 K(+15.1%) |
| Sep 2023 | - | $86.00 K(-49.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2023 | - | $171.00 K(+125.0%) |
| Mar 2023 | - | $76.00 K(-20.8%) |
| Dec 2022 | $96.00 K(-20.7%) | $96.00 K(+20.0%) |
| Jun 2022 | - | $80.00 K(-33.9%) |
| Dec 2021 | $121.00 K(-28.0%) | $121.00 K |
| Dec 2020 | $168.00 K | - |
FAQ
- What is Orchestra BioMed Holdings annual accounts receivable?
- What is the all time high annual accounts receivable for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings annual accounts receivable year-on-year change?
- What is Orchestra BioMed Holdings quarterly accounts receivable?
- What is the all time high quarterly accounts receivable for Orchestra BioMed Holdings?
- What is Orchestra BioMed Holdings quarterly accounts receivable year-on-year change?
What is Orchestra BioMed Holdings annual accounts receivable?
The current annual accounts receivable of OBIO is $99.00 K
What is the all time high annual accounts receivable for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high annual accounts receivable is $168.00 K
What is Orchestra BioMed Holdings annual accounts receivable year-on-year change?
Over the past year, OBIO annual accounts receivable has changed by +$3000.00 (+3.12%)
What is Orchestra BioMed Holdings quarterly accounts receivable?
The current quarterly accounts receivable of OBIO is $115.00 K
What is the all time high quarterly accounts receivable for Orchestra BioMed Holdings?
Orchestra BioMed Holdings all-time high quarterly accounts receivable is $171.00 K
What is Orchestra BioMed Holdings quarterly accounts receivable year-on-year change?
Over the past year, OBIO quarterly accounts receivable has changed by +$29.00 K (+33.72%)